![]()

Head and Consultant Neurologist, Neuroimmunolgy Clinic and Demyelinating Diseases Centre
Clinical Professor Allan Kermode completed medicine at the University of Western Australia and then moved to the Radcliffe Infirmary, Oxford, United Kingdom. He continued neurology studies with the late Professor W Ian McDonald at the National Hospital for Neurological Diseases, Queen Square London, and for his work in the NMR Research Unit he was awarded a Doctor of Medicine from the University of Western Australia. He returned to Perth to complete his clinical neurology training, and then in 1992 he became an NHMRC C.J. Martin Scholar and moved to the National Institutes of Health United States of America to work with Dr Henry McFarland and Dr Steve Jacobson on HTLV-1 and inflammatory neurological disease. He then moved to the Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, to continue this work with Professor Charles Bangham.
He returned to Perth in 1996 to a clinical appointment and private practice, and established The Neuroimmunology Clinic and The Demyelinating Diseases Centre at the ANRI. In recent years he has recommenced an active research programme and collaborations encompassing clinical, radiological, immunological, genetic and epidemiological studies in multiple sclerosis. In addition he has been actively involved in therapeutic clinical trials and has been proactive in creating international collaborations throughout the Asian region.
Latest News |
- ANRI Successful again with Adjunct Assoc Prof Bruno Meloni awarded prestigious National Stroke Foundation Grant to trial Magnesium plus Mild Hypothermia as a Stroke Therapy In Vivo
- ANRI delegates at 21st Combined Biological Siences Meeting 2011 - Won prestigious prizes...."New Investigator" Prize – Dr Carl Adkin..... "Student Poster" Prize – Ms Gurkiran Kaur Flora.......
- Congratulations Prof. Steve Wilton who has had a paper published in British Medical Journal, The Lancet. The paper reports on the results of the worlds first successful trials for treating Duchenne muscular dystrophy, directed by Steve in the UK consortium....
